CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $5.8B, above the global median of $1.15B
- PositionPrice-to-book is 0.91×, lower than 95% of its Medical Instruments & Supplies peers (median 2.65×)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.80BUSDvs all stocks (USD)
Revenue (TTM)
5.21BUSDvs all stocks (USD)
Profit Margin
-4.21%vs Medical Instruments & Supplies peers
Beta
0.5580xvs all stocks
52-Week Change
16.73%vs all stocks
Market Capitalization
5.80BUSDvs all stocks (USD)
Enterprise Value
10.67BUSDvs all stocks (USD)
Forward P/E
15.20xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.11xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.9084xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.05xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
14.74xvs Medical Instruments & Supplies peers
Gross Margin
61.17%vs Medical Instruments & Supplies peers
Profit Margin
-4.21%vs Medical Instruments & Supplies peers
Operating Margin
4.74%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.42%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-3.28%vs Medical Instruments & Supplies peers
Revenue (TTM)
5.21BUSDvs all stocks (USD)
Revenue per Share (TTM)
14.70USDUpdated Jul 18, 2026Quarterly Revenue Growth
9.40%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
3.16BUSDvs all stocks (USD)
EBITDA (TTM)
736.00MUSDvs all stocks (USD)
Net Income (TTM)
-219.00MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
9.41%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
340.00MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
238.50MUSDvs all stocks (USD)
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
71.00MUSDFY2025 · Dec 31, 2025Revenue
5.10BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
2.05BUSDFY2025 · Dec 31, 2025Gross Profit
3.05BUSDFY2025 · Dec 31, 2025Operating Income
188.00MUSDvs all stocks (USD)
Pre-tax Income
-317.00MUSDFY2025 · Dec 31, 2025Income Tax Expense
35.00MUSDFY2025 · Dec 31, 2025Net Income
-352.00MUSDFY2025 · Dec 31, 2025EBIT
104.00MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
621.00MUSDFY2025 · Dec 31, 2025Research & Development
371.00MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
2.23BUSDFY2025 · Dec 31, 2025Non-operating Interest Income
12.00MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
421.00MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-352.00MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-8.00MUSDFY2025 · Dec 31, 2025Operating Cash Flow
240.00MUSDFY2025 · Dec 31, 2025Free Cash Flow
-109.00MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
397.00MUSDFY2025 · Dec 31, 2025Income Tax Paid
59.00MUSDFY2025 · Dec 31, 2025Interest Paid
380.00MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-352.00MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
421.00MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-32.00MUSDFY2025 · Dec 31, 2025Stock-based Compensation
149.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
56.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-148.00MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
108.00MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
38.00MUSDFY2025 · Dec 31, 2025Capital Expenditures
-349.00MUSDFY2025 · Dec 31, 2025Net Acquisitions
-122.00MUSDFY2025 · Dec 31, 2025Purchase of Investments
-11.00MUSDFY2025 · Dec 31, 2025Sale of Investments
8.00MUSDFY2025 · Dec 31, 2025Other Investing Activity
7.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-467.00MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
3.36BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-3.10BUSDFY2025 · Dec 31, 2025Other Financing Charges
-36.00MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
225.00MUSDFY2025 · Dec 31, 2025Shares Outstanding
356.40MSharesUpdated Jul 18, 2026Float Shares
44.92MSharesUpdated Jul 18, 2026Shares Short
3.99MSharesUpdated Jul 18, 2026Short Ratio
8.80daysvs all stocks
Short % of Shares Outstanding
8.86%vs all stocks
% Held by Insiders
87.24%vs all stocks
% Held by Institutions
11.02%vs all stocks
Total Cash (MRQ)
268.00MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.7520USDUpdated Jul 18, 2026Total Debt (MRQ)
5.07BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.7858xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.52xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
17.90USDUpdated Jul 18, 2026Total Assets
14.02BUSDvs all stocks (USD)
Total Current Assets
2.98BUSDFY2025 · Dec 31, 2025Total Liabilities
7.50BUSDFY2025 · Dec 31, 2025Total Non-current Assets
11.04BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
5.58BUSDFY2025 · Dec 31, 2025Total Current Liabilities
1.92BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
383.00MUSDFY2025 · Dec 31, 2025Accounts Receivable
1.22BUSDFY2025 · Dec 31, 2025Inventory
976.00MUSDFY2025 · Dec 31, 2025Accounts Payable
388.00MUSDFY2025 · Dec 31, 2025Short-term Debt
39.00MUSDFY2025 · Dec 31, 2025Other Current Liabilities
487.00MUSDFY2025 · Dec 31, 2025Long-term Debt
5.04BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
521.00MUSDFY2025 · Dec 31, 2025Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025Retained Earnings
-931.00MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
6.52BUSDvs all stocks (USD)
52-Week Low
13.09USDUpdated Jul 18, 202652-Week High
18.91USDUpdated Jul 18, 202652-Week Change
16.73%vs all stocks
Beta
0.5580xvs all stocks
50-Day MA
15.89USDUpdated Jul 18, 2026200-Day MA
16.26USDUpdated Jul 18, 2026Avg 10-Day Volume
355.33KSharesUpdated Jul 18, 2026Avg 30-Day Volume
385.79KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-0.6000USDUpdated Jul 18, 2026Other Income / Expense
-96.00MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.91×, lower than 95% of its Medical Instruments & Supplies peers (median 2.65×)Notable
Price-to-book: 0.91Industry median: 2.65Industry P5: 0.93Peers compared: 65.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.61Profit Margin: -0.04
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 1.52Altman Z-Score: 0.85
Financial Health
Altman Z-Score 0.85: distress zoneCritical
Altman Z-Score: 0.85
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $5.8B, above the global median of $1.15BNotable
Market cap (USD): 5,797,281,181Global Median: 1,146,734,693.424
Revenue is $5.21B, above the global median of $520.53MNotable
Revenue (USD): 5,208,000,000Global Median: 520,528,949.311
Levered free cash flow is $238.5M, above the global median of $16.24MNotable
Levered free cash flow (USD): 238,500,000Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Shenzhen JPT Opto-Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Solaris Energy Infrastructure Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Weatherford International plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
E Ink Holdings Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Amlogic (Shanghai) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Iteq Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Boqian New Materials Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Twist Bioscience Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ford Otomotiv Sanayi A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Saipem S.p.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule